000 | 01727 a2200577 4500 | ||
---|---|---|---|
005 | 20250514072632.0 | ||
264 | 0 | _c20030729 | |
008 | 200307s 0 0 eng d | ||
022 | _a1784-3286 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVanhoof, R | |
245 | 0 | 0 |
_aSurveillance of antibiotic resistance in clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2000-2001. _h[electronic resource] |
260 |
_bActa clinica Belgica _c |
||
300 |
_a111-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aBelgium _xepidemiology |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aDrug Resistance, Multiple |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPneumococcal Infections _xdrug therapy |
650 | 0 | 4 | _aPopulation Surveillance |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
700 | 1 | _aCarpentier, M | |
700 | 1 | _aCartuyvels, R | |
700 | 1 | _aDamée, S | |
700 | 1 | _aFagnart, O | |
700 | 1 | _aGarrino, M G | |
700 | 1 | _aGlupczynski, Y | |
700 | 1 | _aGordts, B | |
700 | 1 | _aGovaerts, D | |
700 | 1 | _aMagerman, K | |
700 | 1 | _aMans, I | |
700 | 1 | _aSurmont, I | |
700 | 1 | _aVan Bossuyt, E | |
700 | 1 | _aVan De Vyvere, M | |
700 | 1 | _aVan Landuyt, H | |
700 | 1 | _aVan Nimmen, L | |
700 | 1 | _aVan Noyen, R | |
773 | 0 |
_tActa clinica Belgica _gvol. 58 _gno. 2 _gp. 111-9 |
|
999 |
_c12618947 _d12618947 |